How can real-world data fuel evidence generation?
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
Exploring the impacts and benefits of a real-world data strategy for long-term care insurance...
Why government and public health agencies contract for the HealthVerity IPGE platform as a trusted...
In the first installment of our HealthVerity IPGE blog series covering the four foundational...
How real-world data (RWD) from open and closed claims and beyond can be layered to better explore...
Patient Identity Resolution: The next era of healthcare data interoperability The HealthVerity...
The intrinsic role of real-world data to help determine the necessity for booster shots as new...
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
A data-rich longitudinal patient journey is key to research and development, commercialization and...
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease marked by immune-mediated damage to the small bile ducts inside the liver. Over time, that injury can lead to cholestasis (reduc...